FDA Inspection 755648 — Adcock Ingram

Adcock Ingram — FEI 3006595261

The FDA completed an inspection of Adcock Ingram on November 28, 2011 in Germiston. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 28, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Germiston (South Africa)